日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening

通过基于结构的虚拟筛选鉴定新型结构类别的 HV1 抑制剂

Martina Piga, Zoltan Varga, Adam Feher, Ferenc Papp, Eva Korpos, Kavya C Bangera, Rok Frlan, Janez Ilaš, Jaka Dernovšek, Tihomir Tomašič, Nace Zidar

Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis

ENR抑制剂化学空间探索:一项综合分析

Kuralt, Vid; Frlan, Rok

Using Subcritical Water to Obtain Polyphenol-Rich Extracts with Antimicrobial Properties

利用亚临界水提取具有抗菌性能的富含多酚的提取物

Žagar, Tjaša; Frlan, Rok; Kočevar Glavač, Nina

Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis

发现针对细菌肽聚糖生物合成的 D-Ala:D-Ala 连接酶的片段命中化合物

Matic Proj, Martina Hrast, Gregor Bajc, Rok Frlan, Anže Meden, Matej Butala, Stanislav Gobec

Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (-)-epicatechin

Mur 连接酶 F 是黄酮类化合物槲皮素、杨梅素和 (-)-表儿茶素的新靶标

Martina Hrast Rambaher, Irena Zdovc, Nina Kočevar Glavač, Stanislav Gobec, Rok Frlan

An Evolutionary Conservation and Druggability Analysis of Enzymes Belonging to the Bacterial Shikimate Pathway

细菌莽草酸途径酶的进化保守性和成药性分析

Frlan, Rok

Essential Oil and Hydrosol Composition of Immortelle (Helichrysumitalicum)

蜡菊(Helichrysumitalicum)精油和纯露成分

Kunc, Nina; Frlan, Antonela; Baričevič, Dea; Kočevar Glavač, Nina; Kokalj Ladan, Meta

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?

在基于片段的药物发现活动中,片段大小的噻唑类化合物是敌是友?

Proj, Matic; Hrast, Martina; Knez, Damijan; Bozovičar, Krištof; Grabrijan, Katarina; Meden, Anže; Gobec, Stanislav; Frlan, Rok

Inhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs

Lepechinia meyenii二萜及其合成类似物对大肠杆菌和金黄色葡萄球菌MurA酶的抑制作用

Macarena Funes Chabán, Martina Hrast, Rok Frlan, Dafni G Graikioti, Constantinos M Athanassopoulos, María Cecilia Carpinella

Efficient and Straightforward Syntheses of Two United States Pharmacopeia Sitagliptin Impurities: 3-Desamino-2,3-dehydrositagliptin and 3-Desamino-3,4-dehydrositagliptin

高效简便地合成两种美国药典收录的西格列汀杂质:3-脱氨基-2,3-脱氢西格列汀和3-脱氨基-3,4-脱氢西格列汀

Sova, Matej; Frlan, Rok; Gobec, Stanislav; Časar, Zdenko